David C Linch - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

David C Linch

Showing results (71-80 of 129) with videos related to

Pageof 13

Sort By:

British Journal of Haematology|April 9, 2013

GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutationsClaire L Green, Kiran Tawana, Robert K Hills, et al.

British Journal of Haematology|July 27, 2005

Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimensKirit M Ardeshna, Nicholaos Kakouros, Wendi Qian, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2007

High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphomaAdrian J C Bloor, Kirsty Thomson, Noha Chowdhry, et al.

British Journal of Haematology|January 21, 2014

Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposureJaimal Kothari, Karl S Peggs, Antonia Bird, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015

Simpson's Paradox and the Impact of Different DNMT3A Mutations on Outcome in Younger Adults With Acute Myeloid LeukemiaRosemary E Gale, Katarina Lamb, Christopher Allen, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008

Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphomaKirsty J Thomson, Emma C Morris, Adrian Bloor, et al.

British Journal of Haematology|June 30, 2015

Autologous stem cell transplantation outcomes in elderly patients with B cell Non-Hodgkin LymphomaSatyen H Gohil, Kirit M Ardeshna, Jonathan M Lambert, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2013

De novo treatment of diffuse large B-cell lymphoma with rituximab, cyclophosphamide, vincristine, gemcitabine, and prednisolone in patients with cardiac comorbidity: a United Kingdom National Cancer Research Institute trialPaul A Fields, William Townsend, Andrew Webb, et al.

British Journal of Haematology|April 4, 2012

Phenotypic heterogeneity and evidence of a founder effect associated with G6PC3 mutations in patients with severe congenital neutropeniaBradley N Smith, Catherine Evans, Akbar Ali, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2004

Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumabIrit Avivi, Suparno Chakrabarti, Donald W Milligan, et al.

Pageof 13

Search research articles

Showing results (71-80 of 129) with videos related to

Sort By:

Pageof 13

British Journal of Haematology|April 9, 2013

GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutationsClaire L Green, Kiran Tawana, Robert K Hills, et al.

British Journal of Haematology|July 27, 2005

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2007

High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphomaAdrian J C Bloor, Kirsty Thomson, Noha Chowdhry, et al.

British Journal of Haematology|January 21, 2014

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015

Simpson's Paradox and the Impact of Different DNMT3A Mutations on Outcome in Younger Adults With Acute Myeloid LeukemiaRosemary E Gale, Katarina Lamb, Christopher Allen, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008

Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphomaKirsty J Thomson, Emma C Morris, Adrian Bloor, et al.

British Journal of Haematology|June 30, 2015

Autologous stem cell transplantation outcomes in elderly patients with B cell Non-Hodgkin LymphomaSatyen H Gohil, Kirit M Ardeshna, Jonathan M Lambert, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2013

British Journal of Haematology|April 4, 2012

Phenotypic heterogeneity and evidence of a founder effect associated with G6PC3 mutations in patients with severe congenital neutropeniaBradley N Smith, Catherine Evans, Akbar Ali, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2004

Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumabIrit Avivi, Suparno Chakrabarti, Donald W Milligan, et al.

Pageof 13